Unlocking the antiviral potential of rosmarinic acid against chikungunya virus via IL-17 signaling pathway
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1396279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Xinfei Liao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Wenzhou Polytechnic, Wenzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Rosmarinic Acid, Depsides, Cinnamates, Chikungunya virus. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The Chikungunya virus is an Alphavirus that belongs to the Togaviridae family and is primarily transmitted by mosquitoes. It causes acute infection characterized by fever, headache, and arthralgia. Some patients also experience persistent chronic osteoarthritis-like symptoms. Dedicated antiviral treatments are currently unavailable for CHIKV. This study aims to explore the potential anti-CHIKV effect of rosmarinic acid using network pharmacology.
Methods
This study employed network pharmacology to predict and verify the molecular targets and pathways associated with ROSA in the context of CHIKV. The analysis outcomes were further validated using molecular docking and in vitro experiments.
Results
The analysis of CHIKV targets using the Kyoto Encyclopedia of Genes and Genomes and MCODE identified IL-17 as an important pathogenic pathway in CHIKV infection. Among the 30 targets of ROSA against CHIKV, nearly half were found to be involved in the IL-17 signaling pathway. This suggests that ROSA may help the host in resisting CHIKV invasion by modulating this pathway. Molecular docking validation results showed that ROSA can stably bind to 10 core targets out of the 30 identified targets. In an in vitro CHIKV infection model developed using 293T cells, treatment with 60 μM ROSA significantly improved the survival rate of infected cells, inhibited 50% CHIKV proliferation after CHIKV infection, and reduced the expression of TNF-α in the IL-17 signaling pathway.
Conclusion
This study provides the first confirmation of the efficacy of ROSA in suppressing CHIKV infection through the IL-17 signaling pathway. The findings warrant further investigation to facilitate the development of ROSA as a potential treatment for CHIKV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wenzhou Polytechnic, Wenzhou, Zhejiang, China.
- Institute of Virology, Wenzhou University, Wenzhou, Zhejiang, China.
- College of Agriculture, Yanbian University, Yanji, Jilin, China.
- Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, Jilin, China.
Zitieren
APA
Liao, X., Xin, J., Yu, Z., Yan, W., Li, C., Cao, L., Zhang, H., & Wang, W. (2024). Unlocking the antiviral potential of rosmarinic acid against chikungunya virus via IL-17 signaling pathway. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1396279
Vancouver
Liao X, Xin J, Yu Z, Yan W, Li C, Cao L, et al. Unlocking the antiviral potential of rosmarinic acid against chikungunya virus via IL-17 signaling pathway. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1396279
BibTeX
@article{Liao2024,
author = {Liao, Xinfei and Xin, Jialiang and Yu, Ziping and Yan, Weiming and Li, Chenghui and Cao, Liang and Zhang, He and Wang, Wei},
title = {Unlocking the antiviral potential of rosmarinic acid against chikungunya virus via IL-17 signaling pathway},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1396279}
}
EUVIMED